Back to ONCYView Full LandscapeView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
7 competitors in Carcinoma, Non-small Cell Lung
PBYIHKI-272
Phase 2JNJJNJ-90301900
Phase 2LLYIMC-1121B (ramucirumab)
Phase 2CASIrecombinant human Angiostatin protein
Phase 2GTHXG1T38
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
REOLYSINPhase 3
Metastatic or Recurrent Squamous Cell Carcinoma of the Lung
Docetaxel, Reolysin and PrednisonePhase 2
Prostate Cancer
Pemetrexed and Reolysin (and safety run-in)Phase 2
Non Small Cell Lung Cancer
Trifluridine TipiracilPhase 2
Anal Cancer Metastatic
Folfox plus Bevacizumab and reolysinPhase 2
Colorectal Cancer
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
